Foresite Capital Management Iv, LLC Portfolio Holdings

Foresite Capital Management Iv, LLC

  • $87.8 Million
  • Q1 2025

Foresite Capital Management Iv, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $87.8 Million distributed in 5 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pharvaris N.V. with a value of $69.2M, Lyell Immunopharma, Inc. with a value of $8.64M, Kura Oncology, Inc. with a value of $7.34M, Relay Therapeutics, Inc. with a value of $2.62M, and Maze Therapeutics Inc with a value of $0.

Examining the 13F form we can see an decrease of $20.9M in the current position value, from $109M to 87.8M.

Foresite Capital Management Iv, LLC is based out at Larkspur, CA

Below you can find more details about Foresite Capital Management Iv, LLC portfolio as well as his latest detailed transactions.

Portfolio value $87.8 Million
Healthcare: $87.8 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 5
  • Current Value $87.8 Million
  • Prior Value $109 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 1 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Foresite Capital Management Iv, LLC Portfolio

Follow Foresite Capital Management Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email